Publications
Download CSV
Download XLSX
Download TXT
Tables
2025 (4)
2024 (528)
2023 (586)
2022 (724)
2021 (1399)
2020 (842)
All (4083)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
EMBO Mol Med
JSON
ISSN
1757-4684
ISSN-L
1757-4676
IUID
8f6afa9bdfdd4c388dfe3314957e2d9c
Modified
2020-11-27T13:14:51.558Z
Created
2020-11-19T19:45:22.465Z
Year 2022
PubMed
DOI
Crossref
A universal SARS-CoV DNA vaccine inducing highly cross-reactive neutralizing antibodies and T cells.
Appelberg S
,
Ahlén G
,
Yan J
, ...,
Mirazimi A
,
Sällberg M
EMBO Mol Med
-
(-) e15821 [2022-08-19; online 2022-08-19]
Category: Biochemistry
Category: Health
Type: Journal article
PubMed
DOI
Crossref
Clinical grade ACE2 as a universal agent to block SARS-CoV-2 variants.
Monteil V
, Eaton B, Postnikova E, ...,
Wirnsberger G
,
Penninger JM
EMBO Mol Med
14
(8) e15230 [2022-08-08; online 2022-07-04]
Category: Biochemistry
Category: Health
Type: Journal article
Year 2021
PubMed
DOI
Crossref
Human soluble ACE2 improves the effect of remdesivir in SARS-CoV-2 infection.
Monteil V
,
Dyczynski M
,
Lauschke VM
, ...,
Penninger JM
,
Mirazimi A
EMBO Mol Med
13
(1) e13426 [2021-01-11; online 2020-12-14]
Category: Biochemistry
Category: Drug Discovery
Funder: H2020
Funder: VR
Type: Journal article
Year 2020
PubMed
DOI
Crossref
Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients.
Stebbing J, Krishnan V, de Bono S, ..., Corbellino M, Sacco Baricitinib Study Group
EMBO Mol Med
12
(8) e12697 [2020-08-07; online 2020-06-24]
Category: Biochemistry
Type: Journal article
SciLifeLab Data Centre
Publications
9.5.1